|
US3312711A
(en)
|
1964-10-01 |
1967-04-04 |
Monsanto Res Corp |
Aryloxy esters of pyridine and furan aliphatic acids
|
|
US3674836A
(en)
|
1968-05-21 |
1972-07-04 |
Parke Davis & Co |
2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
|
|
US4027009A
(en)
|
1973-06-11 |
1977-05-31 |
Merck & Co., Inc. |
Compositions and methods for depressing blood serum cholesterol
|
|
JPS5612114B2
(https=)
|
1974-06-07 |
1981-03-18 |
|
|
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
|
MX7065E
(es)
|
1980-06-06 |
1987-04-10 |
Sankyo Co |
Un procedimiento microbiologico para preparar derivados de ml-236b
|
|
US4450171A
(en)
|
1980-08-05 |
1984-05-22 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
US4448784A
(en)
|
1982-04-12 |
1984-05-15 |
Hoechst-Roussel Pharmaceuticals, Inc. |
1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof
|
|
US4499289A
(en)
|
1982-12-03 |
1985-02-12 |
G. D. Searle & Co. |
Octahydronapthalenes
|
|
JPS6051189A
(ja)
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
|
CA1327360C
(en)
|
1983-11-14 |
1994-03-01 |
William F. Hoffman |
Oxo-analogs of mevinolin-like antihypercholesterolemic agents
|
|
US4613610A
(en)
|
1984-06-22 |
1986-09-23 |
Sandoz Pharmaceuticals Corp. |
Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
|
|
US4686237A
(en)
|
1984-07-24 |
1987-08-11 |
Sandoz Pharmaceuticals Corp. |
Erythro-(E)-7-[3'-C1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
|
|
US4647576A
(en)
|
1984-09-24 |
1987-03-03 |
Warner-Lambert Company |
Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
|
|
EP0216785B1
(en)
|
1984-12-04 |
1991-01-30 |
Sandoz Ag |
Indene analogs of mevalonolactone and derivatives thereof
|
|
US4668794A
(en)
|
1985-05-22 |
1987-05-26 |
Sandoz Pharm. Corp. |
Intermediate imidazole acrolein analogs
|
|
HUT48208A
(en)
|
1985-10-25 |
1989-05-29 |
Sandoz Ag |
Process for producing heterocyclic analogues of mevalolactone derivatives and pharmaceutical compositions comprising such compounds
|
|
FR2596393B1
(fr)
|
1986-04-01 |
1988-06-03 |
Sanofi Sa |
Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
|
|
FI89493C
(fi)
|
1987-05-22 |
1993-10-11 |
Squibb & Sons Inc |
Foerfarande foer framstaellning av terapeutiskt aktiva, fosforhaltiga inhibitorer av hmg-coa-reduktas och vid foerfarandet anvaendbar ny mellanprodukt
|
|
US4759923A
(en)
|
1987-06-25 |
1988-07-26 |
Hercules Incorporated |
Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
|
|
US4871721A
(en)
|
1988-01-11 |
1989-10-03 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing squalene synthetase inhibitors
|
|
US4924024A
(en)
|
1988-01-11 |
1990-05-08 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing squalene synthetase inhibitors, new intermediates and method
|
|
US5506219A
(en)
|
1988-08-29 |
1996-04-09 |
E. R. Squibb & Sons, Inc. |
Pyridine anchors for HMG-CoA reductase inhibitors
|
|
US5753675A
(en)
|
1989-03-03 |
1998-05-19 |
Novartis Pharmaceuticals Corporation |
Quinoline analogs of mevalonolactone and derivatives thereof
|
|
JPH035988A
(ja)
|
1989-06-01 |
1991-01-11 |
Matsushita Electric Ind Co Ltd |
ダイナミックメモリ
|
|
US5470845A
(en)
|
1992-10-28 |
1995-11-28 |
Bristol-Myers Squibb Company |
Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
|
|
US5731292A
(en)
|
1992-11-12 |
1998-03-24 |
Tanabe Seiyaku Co., Ltd. |
Dihydrochalcone derivatives which are hypoglycemic agents
|
|
CA2102591C
(en)
|
1992-11-12 |
2000-12-26 |
Kenji Tsujihara |
Hypoglycemic agent
|
|
LT3300B
(en)
|
1992-12-23 |
1995-06-26 |
Schering Corp |
Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
|
|
US5594016A
(en)
|
1992-12-28 |
1997-01-14 |
Mitsubishi Chemical Corporation |
Naphthalene derivatives
|
|
US5776983A
(en)
|
1993-12-21 |
1998-07-07 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
US5488064A
(en)
|
1994-05-02 |
1996-01-30 |
Bristol-Myers Squibb Company |
Benzo 1,3 dioxole derivatives
|
|
US5830873A
(en)
|
1994-05-11 |
1998-11-03 |
Tanabe Seiyaku Co., Ltd. |
Propiophenone derivative and a process for preparing the same
|
|
JP2814950B2
(ja)
|
1994-05-11 |
1998-10-27 |
田辺製薬株式会社 |
血糖降下剤
|
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
US5491134A
(en)
|
1994-09-16 |
1996-02-13 |
Bristol-Myers Squibb Company |
Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
|
|
US5541204A
(en)
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
|
US5698527A
(en)
|
1995-08-08 |
1997-12-16 |
Merck & Co., Inc. |
Steroidal glycosides as antihyperlipidemic agents
|
|
JP3034192B2
(ja)
|
1995-11-07 |
2000-04-17 |
田辺製薬株式会社 |
プロピオフェノン誘導体およびその製法
|
|
JP3006513B2
(ja)
|
1995-11-07 |
2000-02-07 |
田辺製薬株式会社 |
医薬組成物
|
|
JP3065235B2
(ja)
|
1995-11-07 |
2000-07-17 |
田辺製薬株式会社 |
プロピオフェノン誘導体およびその製法
|
|
JP3059088B2
(ja)
|
1995-11-07 |
2000-07-04 |
田辺製薬株式会社 |
プロピオフェノン誘導体およびその製法
|
|
AU717743B2
(en)
|
1995-12-13 |
2000-03-30 |
Regents Of The University Of California, The |
Nuclear receptor ligands and ligand binding domains
|
|
US5770615A
(en)
|
1996-04-04 |
1998-06-23 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
DE19622222A1
(de)
|
1996-06-03 |
1997-12-04 |
Hoechst Ag |
Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
|
|
US6537987B1
(en)
|
1996-06-20 |
2003-03-25 |
Pfizer Inc. |
4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors
|
|
HRP970330B1
(en)
|
1996-07-08 |
2004-06-30 |
Bayer Ag |
Cycloalkano pyridines
|
|
AU719726B2
(en)
|
1996-12-26 |
2000-05-18 |
Tanabe Seiyaku Co., Ltd. |
Propiophenone derivatives and process for preparing the same
|
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
|
JPH10245391A
(ja)
|
1997-03-03 |
1998-09-14 |
Dainippon Ink & Chem Inc |
７−グリコシロキシベンゾピラン誘導体を有効成分とする糖尿病治療剤
|
|
GB9713739D0
(en)
|
1997-06-27 |
1997-09-03 |
Karobio Ab |
Thyroid receptor ligands
|
|
CN1255386C
(zh)
|
1997-10-08 |
2006-05-10 |
三共株式会社 |
有取代稠合杂环化合物
|
|
AU766219B2
(en)
|
1998-02-02 |
2003-10-09 |
1149336 Ontario Inc. |
Method of regulating glucose metabolism, and reagents related thereto
|
|
AU3034299A
(en)
|
1998-03-09 |
1999-09-27 |
Fondatech Benelux N.V. |
Serine peptidase modulators
|
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
|
WO2000001389A1
(en)
|
1998-07-06 |
2000-01-13 |
Bristol-Myers Squibb Co. |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
|
|
WO2000015201A2
(en)
|
1998-09-10 |
2000-03-23 |
Forbes Medi-Tech Inc. |
Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other disorders
|
|
US6147089A
(en)
|
1998-09-17 |
2000-11-14 |
Pfizer Inc. |
Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
|
|
BR9915687A
(pt)
|
1998-11-25 |
2001-12-04 |
Nutri Pharma As |
Composição compreendendo proteìna de soja,fibras de dieta e um composto fitoestrogênio eseu uso na prevenção e/ou tratamento de doençascardiovasculares
|
|
AU2157400A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle & Co. |
Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
|
|
GB9828442D0
(en)
|
1998-12-24 |
1999-02-17 |
Karobio Ab |
Novel thyroid receptor ligands and method II
|
|
CA2362549A1
(en)
|
1999-02-24 |
2000-08-31 |
John Hopkins University |
Compositions and methods for modulating serum cholesterol
|
|
US6548529B1
(en)
|
1999-04-05 |
2003-04-15 |
Bristol-Myers Squibb Company |
Heterocyclic containing biphenyl aP2 inhibitors and method
|
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
|
US6515117B2
(en)
*
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
US6432156B1
(en)
|
1999-11-17 |
2002-08-13 |
The Homestead Corp. |
Method of coating materials and materials formed thereby
|
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
|
US6555519B2
(en)
|
2000-03-30 |
2003-04-29 |
Bristol-Myers Squibb Company |
O-glucosylated benzamide SGLT2 inhibitors and method
|
|
US6683056B2
(en)
|
2000-03-30 |
2004-01-27 |
Bristol-Myers Squibb Company |
O-aryl glucoside SGLT2 inhibitors and method
|
|
ATE455785T1
(de)
|
2000-11-02 |
2010-02-15 |
Ajinomoto Kk |
Neue pyrazolderivate und diese enthaltende mittel gegen diabetes
|
|
JP4590158B2
(ja)
|
2001-04-04 |
2010-12-01 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
グルコース再吸収阻害剤およびレチノイド−ｘ受容体モジュレーターを含んで成る併用療法
|
|
WO2002083066A2
(en)
|
2001-04-11 |
2002-10-24 |
Bristol-Myers Squibb Company |
Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
|
|
JP4292570B2
(ja)
|
2001-04-27 |
2009-07-08 |
味の素株式会社 |
Ｎ−置換ピラゾール−ｏ−グリコシド誘導体及びそれらを含有する糖尿病治療薬
|
|
EP1404215B1
(en)
|
2001-06-20 |
2007-08-15 |
Purdue Research Foundation |
Body-member-illuminating pressure cuff for use in optical noninvasive measurement of blood parameters
|
|
JP4490109B2
(ja)
|
2002-03-22 |
2010-06-23 |
キッセイ薬品工業株式会社 |
グルコピラノシルオキシベンジルベンゼン誘導体の結晶
|
|
ES2567571T3
(es)
|
2003-03-14 |
2016-04-25 |
Astellas Pharma Inc. |
Derivados de C-glucósido y sales de los mismos
|
|
CN1761676A
(zh)
|
2003-04-01 |
2006-04-19 |
大正制药株式会社 |
杂芳基5－硫代－β－D－吡喃葡糖苷衍生物及含有该衍生物的糖尿病治疗药
|
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
|
UA86042C2
(en)
|
2003-08-01 |
2009-03-25 |
Янссен Фармацевтика Н.В. |
Substituted indazole-o-glucosides
|
|
LT2896397T
(lt)
|
2003-08-01 |
2017-11-27 |
Mitsubishi Tanabe Pharma Corporation |
Nauji junginiai, turintys inhibitorinį aktyvumą prieš nuo natrio priklausomą gliukozės transporterį
|
|
US7375090B2
(en)
|
2003-08-26 |
2008-05-20 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof
|
|
ATE557013T1
(de)
|
2004-03-16 |
2012-05-15 |
Boehringer Ingelheim Int |
Glucopyranosyl-substituierte benzol-derivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
US7393836B2
(en)
|
2004-07-06 |
2008-07-01 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
|
|
DE102004034690A1
(de)
|
2004-07-17 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Methyliden-D-xylopyranosyl-und Oxo-D-xylopyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
TW200606129A
(en)
|
2004-07-26 |
2006-02-16 |
Chugai Pharmaceutical Co Ltd |
Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
|
|
EP1773800A1
(de)
|
2004-07-27 |
2007-04-18 |
Boehringer Ingelheim International GmbH |
D-glucopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
AR051446A1
(es)
|
2004-09-23 |
2007-01-17 |
Bristol Myers Squibb Co |
Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
|
|
JP2006117651A
(ja)
|
2004-09-27 |
2006-05-11 |
Taisho Pharmaceut Co Ltd |
Ｓｇｌｔ２の活性阻害剤
|
|
US20080139484A1
(en)
|
2004-09-29 |
2008-06-12 |
Kissei Pharmaceutical Co., Ltd. |
1(Beta-D-Glycopyranosyl)-3-Substituted Nitrogenous Heterocyclic Compound, Medicinal Composition Containing the Same, and Medicinal Use Thereof
|
|
DE102004048388A1
(de)
|
2004-10-01 |
2006-04-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
D-Pyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
|
WO2007093610A1
(en)
*
|
2006-02-15 |
2007-08-23 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
|
|
US7919598B2
(en)
*
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
|
US7569590B2
(en)
|
2006-09-19 |
2009-08-04 |
Bristol-Myers Squibb Company |
Use of thianecarboxamides as dgat inhibitors
|
|
BRPI1008560B1
(pt)
*
|
2009-02-13 |
2021-08-31 |
Boehringer Ingelheim International Gmbh |
Composição farmacêutica compreendendo um inibidor de sglt2, um inibidor de dpp-iv e opcionalmente um outro agente antidiabético e usos dos mesmos
|
|
CA2812016A1
(en)
|
2013-04-05 |
2014-10-05 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
|
EP3110449B1
(en)
*
|
2014-02-28 |
2023-06-28 |
Boehringer Ingelheim International GmbH |
Medical use of a dpp-4 inhibitor
|
|
MX367404B
(es)
|
2014-06-30 |
2019-08-20 |
Astrazeneca Ab |
Amidas de benzoxazinona como moduladores del receptor de mineralocorticoides.
|
|
AU2017233889B2
(en)
|
2016-03-16 |
2022-07-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition comprising empagliflozin and uses thereof
|
|
EP3508222A4
(en)
|
2016-08-30 |
2020-04-29 |
Niigata University |
MEDICINES FOR REMOVING AGED CELLS
|
|
WO2018142422A1
(en)
|
2017-02-02 |
2018-08-09 |
Indoco Remedies Limited |
Process for the preparation of dapagliflozin
|
|
KR101943382B1
(ko)
|
2017-09-19 |
2019-01-29 |
오토텔릭바이오 주식회사 |
Sglt-2 저해제 및 안지오텐신 수용체 차단제를 포함하는 의약 조성물
|
|
BR112021000139A2
(pt)
|
2018-07-19 |
2021-04-06 |
Astrazeneca Ab |
Métodos de tratamento da hfpef empregando dapagliflozina e composições compreendendo a mesma
|
|
WO2021037400A1
(en)
|
2019-08-30 |
2021-03-04 |
Astrazeneca Ab |
Methods of treating heart failure with reduced ejection fraction with dapagliflozin
|